| 000 | 01640 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513235021.0 | ||
| 264 | 0 | _c20010521 | |
| 008 | 200105s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArima, H | |
| 245 | 0 | 0 |
_aContribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cMay 2001 |
||
| 300 |
_a547-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCaco-2 Cells |
| 650 | 0 | 4 |
_aCyclodextrins _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aIntestinal Absorption _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 | _aSilver Staining |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 |
_aTacrolimus _xpharmacokinetics |
| 650 | 0 | 4 |
_aVinblastine _xpharmacology |
| 650 | 0 | 4 | _abeta-Cyclodextrins |
| 700 | 1 | _aYunomae, K | |
| 700 | 1 | _aHirayama, F | |
| 700 | 1 | _aUekama, K | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 297 _gno. 2 _gp. 547-55 |
|
| 999 |
_c11237928 _d11237928 |
||